Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

NCT01415778 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca